Showing results (71-80 of 82) with videos related to

Sort By:
Pageof 9
Emerging Microbes & Infections|May 20, 2024
Levels of antibodies against the monkeypox virus compared by HIV status and historical smallpox vaccinations: a serological studyDapeng Li, Haiyan Wang, Liqin Sun, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|March 22, 2021
Cytosolic Delivery of Thiolated Neoantigen Nano-Vaccine Combined with Immune Checkpoint Blockade to Boost Anti-Cancer T Cell ImmunityDa Zhang, Ziguo Lin, Ming Wu, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 20, 2025
Impact of different INSTIs on BMI among people living with HIV who newly started ART in Shenzhen, China: a real-world data analysisLukun Zhang, Xinsheng Wu, Yun He, et al.
The Lancet Regional Health. Western Pacific|June 1, 2026
Incidence, recurrence, and determinants of sexually transmitted infections among people with HIV: a multicenter cohort study in China, 2010-2024, with implications for integrated HIV-STI prevention across the Western PacificXi Xiao, Liqin Sun, Yun He, et al.
Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association|June 16, 2019
Preclinical safety of ginsenoside compound K: Acute, and 26-week oral toxicity studies in mice and ratsYonglin Gao, Tong Wang, Guangfei Wang, et al.
Journal of Virology|December 3, 2025
The crosstalk between ubiquitination and GlcNAcylation of CHAF1A regulates HIV-1 latency and reactivationTao Yang, Minghua Chen, Mo Zhou, et al.
Plos Biology|November 11, 2025
The RNA-binding protein RBM39 scaffolds an m⁶A-dependent RNA decay complex that destabilizes Tat transcripts and restricts HIV-1 reactivationXiaohui Deng, Siyi Xie, Mo Zhou, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|September 12, 2022
Higher Risk of Dyslipidemia With Coformulated Elvitegravir, Cobicistat, Emtricitabine, and Tenofovir Alafenamide than Efavirenz, Lamivudine, and Tenofovir Disoproxil Fumarate Among Antiretroviral-Naive People Living With HIV in ChinaLiqin Sun, Yun He, Liumei Xu, et al.
Chinese Medical Journal|January 31, 2023
Low rate of pre-exposure prophylaxis and post-exposure prophylaxis uptake and high prevalence of transmitted drug resistance among newly diagnosed primary HIV infections in Shenzhen, China: a real-world retrospective studyQiaoli Peng, Xiaoning Liu, Xian Tang, et al.
The Journal of Infectious Diseases|April 12, 2026
Plasma GDF-15 levels are associated with HIV reservoir markers independently of inflammation in people with HIV on antiretroviral therapyStephane Isnard, Lena Royston, Carolina A Berini, et al.
Pageof 9